GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Net Margin %

Synergy Pharmaceuticals (FRA:S90) Net Margin % : -311.05% (As of Sep. 2018)


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Synergy Pharmaceuticals's Net Income for the three months ended in Sep. 2018 was €-29.60 Mil. Synergy Pharmaceuticals's Revenue for the three months ended in Sep. 2018 was €9.52 Mil. Therefore, Synergy Pharmaceuticals's net margin for the quarter that ended in Sep. 2018 was -311.05%.

The historical rank and industry rank for Synergy Pharmaceuticals's Net Margin % or its related term are showing as below:

FRA:S90' s Net Margin % Range Over the Past 10 Years
Min: -1333.76   Med: -1333.76   Max: -332.11
Current: -332.11


FRA:S90's Net Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.69 vs FRA:S90: -332.11

Synergy Pharmaceuticals Net Margin % Historical Data

The historical data trend for Synergy Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Net Margin % Chart

Synergy Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1,333.75

Synergy Pharmaceuticals Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -975.80 -393.34 -420.51 -242.30 -311.05

Competitive Comparison of Synergy Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synergy Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Net Margin % falls into.



Synergy Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Synergy Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2017 is calculated as

Net Margin=Net Income (A: Dec. 2017 )/Revenue (A: Dec. 2017 )
=-189.566/14.213
=-1,333.75 %

Synergy Pharmaceuticals's Net Margin for the quarter that ended in Sep. 2018 is calculated as

Net Margin=Net Income (Q: Sep. 2018 )/Revenue (Q: Sep. 2018 )
=-29.603/9.517
=-311.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synergy Pharmaceuticals  (FRA:S90) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Synergy Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy Pharmaceuticals (FRA:S90) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines